MILPITAS, Calif., Oct. 2, 2024 /PRNewswire/ -- Zepp Health Corporation ('Zepp Health' or the 'Company') (NYSE: ZEPP), a global leader in smart wearables and health technology, today announced that it has received a letter from the New York Stock Exchange ('NYSE') dated October 2, 2024 (the 'October Letter'), notifying the Company that it has regained compliance with the NYSE's continued listing criterion of a minimum share price as set forth in Section 802.01C of the NYSE Listed Company Manual (the 'NYSE Minimum Price Continued Listing Criterion').